## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `tb-500-glp1-muscle-loss`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `tb-500-glp1-muscle-loss` v24 · content_hash `958c546f6fc97c09…` · thread_head genesis · 30 DIVs
- **thesis (c3):** Thymosin beta-4 promotes cell migration via actin regulation and supports angiogenesis.
  - c5 [human/active] Phase 1/2 human trials of thymosin beta-4 report good tolerability and no serious peptide-attributable adverse events in wound and cardiac indications.
  - c6 [human/active] No human trials examine TB-500 with GLP-1 agonists or for lean mass preservation during GLP-1 therapy.
  - c7 [human/active] Commercial vendors and clinics market this compound (8 commercial/clinic sources catalogued) — marketing material, not evidence.
  - c10 [human/active] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - c4 [preclinical/active] Rat wound models demonstrate accelerated closure with thymosin beta-4.
  - c23 [mechanistic/active] The claim that lean mass loss was ~45% of total weight lost on semaglutide is speculative and not directly supported by the source s1, which discusses GLP-1 ago
  - c_map_tb-500-glp1-muscle-loss [system/active] Combinatorial mapping (transparent): tb-500 vs glp1-muscle-loss — regen=0.11, degen=0.72, Δ=-0.61. Method: layer_relevance(0.20) × evidence_factor(0.55); catalo
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `tb-500-glp1-muscle-loss`
- **title:** TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping
- **url:** https://miscsubjects.com/a/tb-500-glp1-muscle-loss
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:15.203Z
- **tags:** peptide, topic

## Body

## Regeneration vs degeneration — where this fits

The body breaks down tissue and rebuilds it at the same time. When breakdown exceeds rebuild, lean mass drops. GLP-1 agonists reduce appetite and body weight. Reports show some of that weight comes from lean mass. TB-500 is studied for repair-cell movement and tissue structure repair. This places it in the regeneration column for muscle and connective tissue contexts.

## What it is

TB-500 is a fragment derived from thymosin beta-4. Thymosin beta-4 occurs naturally in many tissues. The fragment is studied for effects on cell migration and actin binding.

## How it works

Thymosin beta-4 binds actin. Actin controls cell shape and movement. When cells move toward damaged areas, repair follows. Studies track this in wound models. TB-500 is the version used in research settings for the same proposed pathway.

## Why it would work (logic chain)

If GLP-1 agonists create caloric deficit, muscle protein breakdown can rise. If repair cells cannot reach stressed muscle fast enough, net loss occurs. If TB-500 increases cell migration and reduces programmed cell death under stress, then more cells stay available for repair. The chain is: deficit occurs, migration signal rises, TB-500 supports migration, net muscle loss slows. This remains a proposed chain. No direct test of the full chain exists in the ledger.

## Why people take it

People take TB-500 when they use GLP-1 agonists and want to keep training. They report interest in faster recovery from exercise and less muscle loss during weight reduction. Clinic sites list the combination for musculoskeletal support during GLP-1 use.

## How many people take it

The ledger contains no population count. No survey or prescription data appear. The number of people who combine TB-500 with GLP-1 agonists is unknown from these sources.

## Evidence inventory

Sources total: 11.  
Studies catalogued: 8.  
Reddit posts: 1.  
X posts: 0.  
Other anecdote sources: 0.  
Human claims: 1.  
Preclinical claims: 2.  
Anecdotal claims: 4.

Human data: one review summarizes DXA scans from GLP-1 trials showing lean mass fractions of weight loss between 25.7 % and 45.5 % (source s1). One review states a phase 1 safety study found recombinant thymosin beta-4 well tolerated with no serious adverse events (source s2).

Preclinical data: one 1999 rat study found thymosin beta-4 accelerated full-thickness wound closure (source s3). One 2026 narrative review states TB-4 and TB-500 promoted angiogenesis and tissue repair in preclinical models but human orthopaedic data are lacking (source s4).

Anecdotal data: one Reddit post in r/crossfit states the user saw significant pain reduction after adding TB-500 (source s7). Four clinic or blog sources discuss TB-500 in the context of GLP-1 use for muscle preservation; these are not controlled trials (sources s5, s6, s9, s10).

## What scientists say

The 1999 rat study showed faster wound closure with thymosin beta-4 (source s3). This proves the peptide can affect repair speed in that model. It does not prove effects on muscle during GLP-1 use in humans.

The 2026 narrative review states preclinical angiogenesis and repair benefits exist but human orthopaedic data are absent (source s4). This proves the gap in human evidence. It does not prove clinical benefit or lack of benefit.

The phase 1 safety review reports no dose-limiting toxicities in healthy volunteers (source s2). This proves short-term tolerability in that small group. It does not prove long-term safety or efficacy for muscle preservation.

The GLP-1 review reports lean mass fractions of weight loss from trial DXA data (source s1). This proves the measured loss in those trials. It does not prove the loss is preventable by any peptide.

## What people say on Reddit

One post in r/crossfit states: "The last few weeks have shown pretty significant reduction in pain since I added TB-500." The poster is a CrossFit participant discussing peptides while noting GLP-1 users seek recovery aids. The report is one person's experience. It shows real-world interest but supplies no controlled comparison.

## What people say on X

The ledger contains zero X posts on this topic.

## What we do not know

No human trial tests TB-500 for lean mass preservation during GLP-1 agonist use. No data show whether any reported pain reduction or training consistency links directly to muscle retention. The fraction of weight lost as lean mass varies by trial and drug; exact mechanisms remain under study. Long-term outcomes for the combination are not reported in the ledger.

## Safety and limits

One phase 1 study in healthy volunteers found recombinant thymosin beta-4 well tolerated with no serious adverse events (source s2). This covers short-term use in that setting only. The 2026 review notes both TB-4 and TB-500 remain banned substances in sports (source s4). No data in the ledger address interactions with GLP-1 agonists. The ledger supplies no dosing information.

## Claims (27)

- **c39** [mechanistic w=0.3] Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
  - who_claims: miscsubjects protocol
  - slot: limitations
- **c7** [human w=0.8] Commercial vendors and clinics market this compound (8 commercial/clinic sources catalogued) — marketing material, not evidence.
  - who_claims: commercial vendors
  - slot: what_is_known
  - sources: s4, s5, s8, s9, s11, s2, s7, s10
- **c_map_tb-500-glp1-muscle-loss** [system w=0.35] Combinatorial mapping (transparent): tb-500 vs glp1-muscle-loss — regen=0.11, degen=0.72, Δ=-0.61. Method: layer_relevance(0.20) × evidence_factor(0.55); catalog.degen_score for GLP-1 muscle loss / sarcopenia.
  - who_claims: grok/4.3-populate
  - slot: what_is_known
- **c38** [system w=0.35] TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
  - who_claims: miscsubjects protocol
  - slot: what_it_is
- **c1** [human w=0.8] In STEP 1, lean mass loss was ~45% of total weight lost on semaglutide.
  - who_claims: system/unknown
  - slot: mechanism
  - sources: s1
- **c2** [human w=0.8] In SURMOUNT-1, lean mass loss fraction was ~26% on tirzepatide.
  - who_claims: system/unknown
  - slot: mechanism
  - sources: s1
- **c3** [human w=0.8] Thymosin beta-4 promotes cell migration via actin regulation and supports angiogenesis.
  - who_claims: system/unknown
  - slot: mechanism
  - sources: s2
- **c5** [human w=0.8] Phase 1/2 human trials of thymosin beta-4 report good tolerability and no serious peptide-attributable adverse events in wound and cardiac indications.
  - who_claims: system/unknown
  - slot: what_is_known
  - sources: s2
- **c6** [human w=0.8] No human trials examine TB-500 with GLP-1 agonists or for lean mass preservation during GLP-1 therapy.
  - who_claims: system/unknown
  - slot: what_is_unknown
  - sources: s2
- **c10** [human w=0.8] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - who_claims: system/protocol
  - slot: disclaimer
- **c4** [preclinical w=0.5] Rat wound models demonstrate accelerated closure with thymosin beta-4.
  - who_claims: system/unknown
  - slot: what_is_known
  - sources: s3
- **c23** [mechanistic w=0.4] The claim that lean mass loss was ~45% of total weight lost on semaglutide is speculative and not directly supported by the source s1, which discusses GLP-1 agonists in general but does not provide specific data on semaglutide's effect on lean mass.
  - who_claims: kimi/moonshot-v1-8k (adversary)
- **c14** [anecdotal w=0.3] Reddit anecdote in context of peptides, with mentions of Ozempic/GLP-1 users seeking recovery aids.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s7
- **c20** [anecdotal w=0.3] Anecdotal reports from Reddit users suggest that individuals using GLP-1 agonists for weight loss are seeking recovery aids, potentially indicating a user-driven interest in mitigating lean mass loss.
  - who_claims: kimi/moonshot-v1-8k
  - slot: who_claims_what
  - sources: s7
- **c27** [anecdotal w=0.3] Discusses stacking TB-500/BPC with GLP-1s like semaglutide/tirzepatide for muscle preservation during weight loss; anecdotal community advice on protocols (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s12
- **c28** [anecdotal w=0.3] Users discuss TB-500 with semaglutide noting muscle loss risks and recovery anecdotes (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s13
- **c29** [anecdotal w=0.3] Mentions TB-500 alongside GLP-1 microdosing for muscle/joint support; anecdotal dosing discussion (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s14
- **c30** [anecdotal w=0.3] User shares personal stack including TB-500 with GLP-1s for muscle preservation; anecdotal results like maintained strength (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s15
- **c31** [anecdotal w=0.3] Thread on semaglutide muscle loss concerns, with some mentions of peptides like TB-500 in comments for mitigation (anecdotal).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s16
- **c32** [anecdotal w=0.3] User documenting use of BPC-157 + TB-500 (Wolverine Stack) for ACL/meniscus recovery while on or considering GLP-1 context; anecdotal recovery protocol 5 days on/2 off.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s17
- **c33** [anecdotal w=0.3] Discussion on muscle loss from tirzepatide/GLP-1; user mentions stacking with BPC-157/TB-500 for muscle preservation; anecdotal experiences of strength loss and recovery via training/protein.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s18
- **c34** [anecdotal w=0.3] Peptide cheat sheet including TB-500 for muscle repair/inflammation with GLP-1s like semaglutide/tirzepatide/retatrutide; anecdotal stacking protocols and dosing examples labeled as educational.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s19
- **c35** [anecdotal w=0.3] User trial of TB-500/BPC-157 for 90 days in CrossFit context, noting potential muscle loss concerns with GLP-1s like semaglutide; mixed anecdotal outcomes on peptides.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s20
- **c36** [anecdotal w=0.3] X post on peptide stacks pairing TB-500 with GLP-1s (semaglutide/tirzepatide) for fat loss and muscle recovery; anecdotal benefits listed.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s21
- **c37** [anecdotal w=0.3] X post recommending BPC-157 + TB-500 stack with GLP-1s for muscle retention during fat loss; dosing not specified, anecdotal research use.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s22
- **c13** [speculative w=0.12] Apr 2026 blog on stacking TB-500 (among others) to counteract muscle loss from GLP-1 weight loss drugs via satellite cell activation and anti-apoptosis effects.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s6
- **c17** [speculative w=0.12] Integrative medicine site promotes combining their GLP-1 peptide therapy with TB-500 (Thymosin Beta-4) and BPC-157 specifically for muscle repair, growth, and preserving muscle mass during weight loss, contrasting with synthetic GLP-1s that cause muscle loss.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s10

## Voxel graph (27 atoms · 59 edges)
- full graph: https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (22)
- chain valid: yes · head: `5a8b972710407781`

### s1 · review · http_403
- title: Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonist Effects
- url: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.067676
- summary: Summarizes DXA data from major GLP-1 trials on lean mass fractions of weight loss.
- quote: Semaglutide has been associated with loss of lean mass up to 40% of total weight loss... In STEP 1... yielding a fraction of weight lost from lean mass of 45.5%. ... SURMOUNT-1... yielding a fraction of weight lost from lean mass of 25.7%.
- claim_ids: c1, c2
- hash: `b0672295dc3a4e5e`

### s2 · review · ok
- title: TB4 and TB-500 Peptide Therapy | What to Know in 2026
- url: https://www.innerbody.com/thymosin-beta-4-and-tb-500
- summary: Reviews human trial safety data and mechanistic actions of thymosin beta-4/TB-500.
- quote: A phase 1 safety study in healthy volunteers demonstrated that recombinant thymosin beta-4 was well tolerated... no dose-limiting toxicities or serious adverse events... Early human trials show it is safe and biologically active.
- claim_ids: c3, c5, c6, c7
- hash: `72fce1583a1b9c20`

### s3 · pubmed · ok
- title: Thymosin beta4 accelerates wound healing
- url: https://pubmed.ncbi.nlm.nih.gov/10469335/
- summary: 1999 rat study establishing preclinical wound healing acceleration.
- quote: we investigated whether the angiogenic thymic peptide thymosin beta4 (Tbeta4) enhanced wound healing in a rat full thickness wound model.
- claim_ids: c4
- hash: `ce5d5b4f6c451fbc`

### s4 · review · ok
- title: Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
- url: https://pubmed.ncbi.nlm.nih.gov/41476424/
- summary: 2026 narrative review noting preclinical benefits of TB-500 for tissue repair but lack of human orthopaedic evidence; no specific GLP-1 mention but relevant to muscle contexts.
- quote: TB-4 and its derivative TB-500 promoted angiogenesis and tissue repair in preclinical models, but human orthopaedic data are lacking, and both remain banned substances in sports.
- claim_ids: c7
- hash: `7d24c5ec67068dde`

### s5 · medical · ok
- title: TB-500 with GLP-1: Best Protocol
- url: https://formblends.com/articles/peptide-hub/tb-500-with-glp-1-best-protocol
- summary: Clinic article from Apr 2026 detailing protocol for combining TB-500 with GLP-1 agonists specifically for musculoskeletal recovery and lean mass support during weight loss.
- quote: TB-500 supports the musculoskeletal system by accelerating repair of exercise-induced damage, helping patients maintain consistent training schedules.
- claim_ids: c7
- hash: `aeb20e722c41196a`

### s6 · medical · ok
- title: Peptide Stacking for Muscle Preservation on GLP-1s: The Complete Protocol
- url: https://peptiq.io/blog/peptide-stacking-muscle-preservation-glp1
- summary: Apr 2026 blog on stacking TB-500 (among others) to counteract muscle loss from GLP-1 weight loss drugs via satellite cell activation and anti-apoptosis effects.
- quote: Research demonstrates TB-500 reduces muscle cell apoptosis (programmed death) under stress conditions, including caloric deficit. Users running GLP-1s alongside TB-500 consistently report better muscle retention and faster recovery from resistance training.
- claim_ids: c13
- hash: `27c4b04a0cd7b07b`

### s7 · reddit · ok
- title: Thoughts on BPC-157?
- url: https://www.reddit.com/r/crossfit/comments/1m6zca5/thoughts_on_bpc157/
- summary: Reddit anecdote in context of peptides, with mentions of Ozempic/GLP-1 users seeking recovery aids.
- quote: The last few weeks have shown pretty significant reduction in pain since I added TB-500.
- claim_ids: c14, c20, c7
- hash: `44f222793ebbb203`

### s8 · other · ok
- title: BPC157/TB500
- url: https://glp1forum.com/threads/bpc157-tb500.13222/
- summary: GLP-1 forum thread (Mar 2026) with user anecdotes on using TB-500/BPC-157 for injury recovery while on or considering GLP-1 therapies.
- quote: Now - i cant train until i get this sorted and it heals without surgery, but i am running GH to help heal it, as well as our friend BPC157/TB500
- claim_ids: c7
- hash: `cb7ca09d16685614`

### s9 · medical · ok
- title: The Wolverine Peptide Stack: A Clinical Guide for Injury Recovery, GH Restoration, and Muscle Preservation on GLP-1s
- url: https://denverregenerativemedicine.com/wolverine-peptide-stack-injury-recovery-gh-restoration-glp1/
- summary: Clinic guide explicitly recommends TB-500 (as part of Wolverine stack with BPC-157 etc.) to help preserve lean muscle mass for patients on GLP-1 agonists like semaglutide/tirzepatide, citing muscle loss concerns and synergistic tissue support.
- quote: GLP-1 medications like Semaglutide are clinically associated with lean muscle loss alongside fat loss; the Wolverine stack may help offset this when combined with adequate protein intake and resistance training.
- claim_ids: c7
- hash: `ed13d1b4ddca16f8`

### s10 · medical · ok
- title: GLP-1 | Delaware Integrative Medicine
- url: https://delawareintegrativemedicine.com/glp-1/
- summary: Integrative medicine site promotes combining their GLP-1 peptide therapy with TB-500 (Thymosin Beta-4) and BPC-157 specifically for muscle repair, growth, and preserving muscle mass during weight loss, contrasting with synthetic GLP-1s that cause muscle loss.
- quote: To amplify these benefits, we harness the synergistic and complimentary effects of pairing GLP-1 with BCP-157 and TB-500 peptides. This strategic combination optimizes fat loss while preserving valuable muscle mass, paving the way for sustainable weight management and a healthier lifestyle.
- claim_ids: c17, c7
- hash: `fa85698b1ec2fc9c`

### s11 · other · ok
- title: 5 Best Peptides to Stack With Tirzepatide for Weight Loss
- url: https://www.redfoxpeptides.is/best-peptides-to-stack-with-tirzepatide/
- summary: Peptide research article recommends stacking TB-500 with tirzepatide (GLP-1/GIP agonist) for muscle preservation, recovery, and reducing inflammation during weight loss, alongside other peptides like BPC-157 and GH secretagogues; includes user anecdote on similar stacking.
- quote: TB-500 provides systemic recovery support, reducing inflammation and improving flexibility during exercise protocols.
- claim_ids: c7
- hash: `ee6d8761372b82a0`

### s12 · reddit · ok
- title: Peptide stacking cheat sheet. What goes together and why
- url: https://www.reddit.com/r/NTNPerformance/comments/1tc5a9d/peptide_stacking_cheat_sheet_what_goes_together/
- summary: Discusses stacking TB-500/BPC with GLP-1s like semaglutide/tirzepatide for muscle preservation during weight loss; anecdotal community advice on protocols (anecdotal, not advice).
- quote: The biggest risk on any GLP-1 cut is losing muscle along with fat. GH support may help protect against that especially when combined with high protein and training. ... TB-500 is studied for broader soft tissue remodeling and mobility .
- claim_ids: c27
- hash: `a51c9e362a65d8e2`

### s13 · reddit · ok
- title: Peptides for faster recovery
- url: https://www.reddit.com/r/workout/comments/1tg0egc/peptides_for_faster_recovery/
- summary: Users discuss TB-500 with semaglutide noting muscle loss risks and recovery anecdotes (anecdotal, not advice).
- quote: TB-500 don't accelerate recovery from injury as many claim. They minimize inflammation and reduce pain. semaglutide”. Which means 35-40% of the ... You lose muscle mass as well as fat.
- claim_ids: c28
- hash: `9f05231ae91106e4`

### s14 · reddit · ok
- title: microdosing GLP-1s for maintenance and what I'm seeing ...
- url: https://www.reddit.com/r/GLP1microdosing/comments/1su5b47/physician_perspective_microdosing_glp1s_for/
- summary: Mentions TB-500 alongside GLP-1 microdosing for muscle/joint support; anecdotal dosing discussion (anecdotal, not advice).
- quote: TB-500 is more systemic — muscle, joint, inflammation . For chronic skeletal issues like yours, TB-500 might be worth exploring with your ...
- claim_ids: c29
- hash: `733e9c939fed39e3`

### s15 · reddit · ok
- title: 💪 The Muscle-Saving Stack for GLP-1 Users (Don’t Let Fat Loss Kill Your Gains)
- url: https://www.reddit.com/r/BodyHackGuide/comments/1k0ndxq/the_musclesaving_stack_for_glp1_users_dont_let/
- summary: User shares personal stack including TB-500 with GLP-1s for muscle preservation; anecdotal results like maintained strength (anecdotal, not advice).
- quote: GLP-1s like Tirzepatide, Retatrutide, and Semaglutide ... can indirectly cause muscle loss ... 3. BPC-157 + TB-500 • Keeps joints, tendons, and soft tissue resilient • I microdose 2x/week to avoid injury while cutting heavy
- claim_ids: c30
- hash: `d1491af1f5c8635c`

### s16 · reddit · ok
- title: Semaglutide reduces muscle mass?
- url: https://www.reddit.com/r/Peptides/comments/14zorm9/semaglutide_reduces_muscle_mass/
- summary: Thread on semaglutide muscle loss concerns, with some mentions of peptides like TB-500 in comments for mitigation (anecdotal).
- quote: In one of the GLP-1 clinical trials people lost 0.4 pounds of muscle for every pound of fat lost . That was somewhat concerning because that ...
- claim_ids: c31
- hash: `0c9a13db575bd11d`

### s17 · reddit · ok
- title: Documenting My ACLR + Meniscus Repair Journey – Trying the “Wolverine Stack” (BPC-157 + TB-500)
- url: https://www.reddit.com/r/ACL/comments/1jwe0oe/documenting_my_aclr_meniscus_repair_journey/
- summary: User documenting use of BPC-157 + TB-500 (Wolverine Stack) for ACL/meniscus recovery while on or considering GLP-1 context; anecdotal recovery protocol 5 days on/2 off.
- quote: I started taking BPC-157 and TB-500 —a combo often called the “Wolverine Stack”—to help support my recovery.
- claim_ids: c32
- hash: `4acaf1f6e4dfdb73`

### s18 · reddit · ok
- title: To everyone freaking out about “muscle wasting”...
- url: https://www.reddit.com/r/tirzepatidecompound/comments/1igpatr/to_everyone_freaking_out_about_muscle_wasting/
- summary: Discussion on muscle loss from tirzepatide/GLP-1; user mentions stacking with BPC-157/TB-500 for muscle preservation; anecdotal experiences of strength loss and recovery via training/protein.
- quote: 71F and stacking T & R and BCP157/TB500. I need muscles too!
- claim_ids: c33
- hash: `30cf880e44e8275b`

### s19 · reddit · ok
- title: peptides cheatsheet
- url: https://www.reddit.com/r/Biohackers/comments/1t95zs0/peptides_cheatsheet/
- summary: Peptide cheat sheet including TB-500 for muscle repair/inflammation with GLP-1s like semaglutide/tirzepatide/retatrutide; anecdotal stacking protocols and dosing examples labeled as educational.
- quote: TB-500 – cuts down inflammation, helps muscle repair and flexibility. ... Wolverine (BPC + TB-500) – soft tissue and recovery
- claim_ids: c34
- hash: `0f085e8036ee77fc`

### s20 · reddit · ok
- title: Peptides are all hype?
- url: https://www.reddit.com/r/crossfit/comments/1pv5qpz/peptides_are_all_hype/
- summary: User trial of TB-500/BPC-157 for 90 days in CrossFit context, noting potential muscle loss concerns with GLP-1s like semaglutide; mixed anecdotal outcomes on peptides.
- quote: After hearing all the hype around peptides, specifically from Andrew Hiller and the Sevan crew, I gave TB500 /BPC-157 a try for 90 days.
- claim_ids: c35
- hash: `1d2f26f24505f2d9`

### s21 · x · ok
- title: peptides stack post
- url: https://x.com/gr8tful88/status/2071404994192974208
- summary: X post on peptide stacks pairing TB-500 with GLP-1s (semaglutide/tirzepatide) for fat loss and muscle recovery; anecdotal benefits listed.
- quote: Muscle recovery: BPC-157, TB-500. Repair tendons, ligaments, and soft tissue damage faster than rest alone. ... Fat loss: Semaglutide, Tirzepatide, GLP-1 agonists suppress appetite
- claim_ids: c36
- hash: `3568e16149bde304`

### s22 · x · ok
- title: Best Peptide Stack for Fat Loss & Muscle Retention
- url: https://x.com/peptivaresearch/status/2067779091047043553
- summary: X post recommending BPC-157 + TB-500 stack with GLP-1s for muscle retention during fat loss; dosing not specified, anecdotal research use.
- quote: The Best Peptide Stack for Fat Loss & Muscle Retention ✅ GLP-1s (Tirzepatide, Retatrutide) - Suppress hunger & force fat loss. ✅GH Peptides ... ✅BPC-157 + TB-500 - Keep joints & tendons healthy.
- claim_ids: c37
- hash: `5a8b972710407781`

## Provenance (24 model passes)
- chain valid: yes · head: `d709a58dd52e1c2f`

- synthesize_body · grok/grok-4.3 · 2026-06-29T14:21 · hash `9713de3b04e2`
- sources · grok-4.3 · 2026-06-29T17:20 · hash `62071121e223`
- sources · grok-4.3 · 2026-06-29T17:21 · hash `c2030a751322`
- repair · repair · 2026-06-29T19:14 · hash `7dc7e2c16267`
- repair · repair · 2026-06-29T19:23 · hash `6322b2aaa496`
- claim · fill-slots · 2026-06-29T20:28 · hash `0bb826b0aee7`
- claim · fill-slots · 2026-06-29T20:28 · hash `06c6d13beb23`
- voxel_divide · owner · 2026-07-17T02:42 · hash `d709a58dd52e`

## Question graph
- questions: 0 · evidence ingests: 3

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tb-500-glp1-muscle-loss","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tb-500-glp1-muscle-loss|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tb-500-glp1-muscle-loss|tier|assertion`
- **iMessage ask:** `tb-500-glp1-muscle-loss|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `tb-500-glp1-muscle-loss`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-glp1-muscle-loss/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*